Form 13-F position report

DEEP MEDICINE ACQUISITION C

Reported by Mint Tower Capital Management B V

DMAQR CUSIP 243733110 Manager CIK 0001666606

Reported 194,190 shares, unchanged from the prior quarter.

Reported value -40.0%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value < 0.01% This manager · Q2 2022
Shares 194,190 Quarter-end amount reported
Reported value $21,000 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 62000
2022-03-31 35000
2022-06-30 21000
2022-09-30 8000
2022-12-31 12000
2023-03-31 28000
2023-06-30 31000
2023-09-30 68000
2023-12-31 58000
2024-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

10 quarters
Quarterly reported position history for DEEP MEDICINE ACQUISITION C held by Mint Tower Capital Management B V.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2024 Reduced 0 -194,190 (-100.0%) 0 $0 2024-05-14
Q4 2023 Unchanged 194,190 0 (0.0%) 0.01% $58,000 2024-02-14
Q3 2023 Unchanged 194,190 0 (0.0%) 0.01% $68,000 2023-11-13
Q2 2023 Unchanged 194,190 0 (0.0%) < 0.01% $31,000 2023-08-10
Q1 2023 Unchanged 194,190 0 (0.0%) < 0.01% $28,000 2023-05-09
Q4 2022 Unchanged 194,190 0 (0.0%) < 0.01% $12,000 2023-02-13
Q3 2022 Unchanged 194,190 0 (0.0%) < 0.01% $8,000 2022-11-14
Q2 2022 Unchanged 194,190 0 (0.0%) < 0.01% $21,000 2022-08-05
Q1 2022 Unchanged 194,190 0 (0.0%) < 0.01% $35,000 2022-04-29
Q4 2021 New 194,190 +194,190 (0.0%) < 0.01% $62,000 2022-02-04

Who else reported the position

32 managers reported DEEP MEDICINE ACQUISITION C for Q2 2022.

Managers reporting DEEP MEDICINE ACQUISITION C in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
COWEN AND COMPANY LLC Added 1,742,299 +90,700 0.02% $192,000 3 qtrs
MANGROVE PARTNERS Unchanged 1,500,000 0 < 0.01% $165,000 3 qtrs
Owl Creek Asset Management L P Unchanged 750,000 0 < 0.01% $83,000 3 qtrs
Yakira Capital Management Inc Unchanged 750,000 0 0.01% $83,000 3 qtrs
Hudson Bay Capital Management LP Unchanged 600,000 0 < 0.01% $66,000 3 qtrs
Shaolin Capital Management LLC Unchanged 506,323 0 < 0.01% $56,000 3 qtrs
HGC Investment Management Inc Unchanged 300,000 0 < 0.01% $54,000 3 qtrs
K2 PRINCIPAL FUND L P Unchanged 475,000 0 < 0.01% $52,000 3 qtrs
AQR Arbitrage LLC Unchanged 375,000 0 < 0.01% $41,000 3 qtrs
D E Shaw & Co Inc Unchanged 296,800 0 < 0.01% $33,000 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 05, 2022
Filing type
13F-HR
Position type
RIGHT 09/30/2028

Voting authority reported

Sole
194,190
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.